How to Buy Maplight Therapeutics Stock

Maplight Therapeutics Inc

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders.

Maplight Therapeutics stock last closed at $27.96, up 0.76% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Maplight Therapeutics stock is currently +128.43% from its 52-week low of $12.24, and -15.99% from its 52-week high of $33.28.

As of Jun 15, 2026, there are 45.35M shares of MPLT outstanding. The market value of MPLT is $1.27B. In the last 24 hours, 203,000 MPLT shares were traded.

How to Buy Maplight Therapeutics Stock

Wondering how to invest in Maplight Therapeutics stock? Here's how.

  1. Figure out where to buy Maplight Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you choose where to buy Maplight Therapeutics stock.
  2. Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Fund your brokerage account: Choose your payment method and add your details.
  4. Analyze Maplight Therapeutics stock: The Maplight Therapeutics ticker symbol is MPLT. Is Maplight Therapeutics stock a good investment? Should you buy shares of MPLT? How do MPLT's underlying business fundamentals look? Do top analysts think Maplight Therapeutics is a good buy? Why has MPLT's stock price moved recently? (Hint: Our stock research tools can help you evaluate if MPLT is a good stock to buy).
  5. Place your MPLT trade: Decide if you will purchase MPLT shares at the current market price or use a limit order to purchase MPLT stock at a particular price.
  6. Get key alerts regarding your MPLT investment: Create a watchlist to get the latest news on your position in Maplight Therapeutics stock.

Step 1: Figure out where to buy Maplight Therapeutics stock

You need an online brokerage account in order to access the NASDAQ market and buy MPLT shares.

A brokerage account enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

In our opinion, eToro is the best online stock brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to world markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
  • Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've picked the right brokerage, the next step is to fill out some personal details so you are able to invest in MPLT stock today.

How to Start a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to open a new trading account.
  1. Send your application by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you've opened your account on the best stock trading app, you can securely and quickly fund your account:

Check out the walkthrough below for more details transferring money into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Maplight Therapeutics stock

Once you have decided on the best place to buy Maplight Therapeutics stock, it's absolutely critical to evaluate their stock prior to investing, so you can comprehend the risk and upside.

Maplight Therapeutics Numbers

MPLT Price
$27.96
1w %
-5.09%
1y %
N/A
5y %
N/A
P/E
N/A
P/B
3.17x
P/S
N/A
PEG
N/A
Revenue
N/A
Earnings
N/A
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$1.27B
Next Earnings
N/A
Next Dividend
N/A

Maplight Therapeutics Overview

WallStreetZen was created to help everyday investors do more accurate fundamental analysis in less time.

You can view all of the due diligence checks on MPLT's stock page.

Is MPLT stock properly valued?

You can use many financial metrics, analyses, models, and charts to gauge MPLT's fair value.

Using relative valuations measures:

  • MPLT may be undervalued based on its P/B ratio of 3.17x, relative to Biotechnology industry P/B ratio of 4.89x

You can access more valuation research on MPLT's stock here.

A quick look at MPLT Financials

Positive Financial Indicators:

  • There are more short-term assets than short-term liabilities on the MPLT balance sheet.
  • There are more short-term assets than long-term liabilities on the MPLT balance sheet.
  • MPLT has a low debt to equity ratio of 0.05.

Is it a good time to buy Maplight Therapeutics stock, according to Wall Street analysts?

Out of 6 sell side analysts who track MPLT, the consensus analyst rating on Maplight Therapeutics is a Strong Buy

Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.

Latest MPLT Analyst Recommendations

Sumant Kulkarni, a top 39% analyst from Canaccord Genuity initiates coverage on MPLT with a strong buy rating and announces their MPLT price target of $35.00, on Mar 19, 2026.

You can dive deeper into what analysts are projecting on the Maplight Therapeutics stock forecast page.

MPLT Technicals

SMA10
28.64
SMA20
28.68
SMA50
28.63
SMA100
23.38
SMA200
N/A
MACD
0.1
MACD Signal
0.29
MACD Histogram
-0.19
RSI
48.08
Stochastic %K
55.84
Stochastic %D
59.27
StochRSI %K
44.75
StochRSI %D
48.56

Are MPLT executives and large shareholders buying or selling the stock?

Over the last 12 months, executives and large shareholders at MPLT have bought more shares than they have sold.

Christopher A. Kroeger, Chief Executive Officer of MPLT, was the latest MPLT insider to sell. They sold $3,209,426.03 worth of MPLT stock on May 18, 2026.

Get more info about who owns MPLT shares here.

Does MPLT stock generate passive income?

No, Maplight Therapeutics doesn't provide an income stream by paying out dividends.

MPLT Social Trading Data

One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Place your MPLT trade

There are two main order types:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are usually fine.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at a given price limit, place a limit order.

Press the Open Trade button and eToro will execute the order.

If you want more assistance investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get key alerts regarding your MPLT investment

Now that you own some shares in MPLT, you'll want to stay up-to-date on your company.

Add MPLT to a watchlist to track your MPLT stock.

MPLT Feed

How to Buy Stock in Maplight Therapeutics

To reiterate, here are the 6 steps you need to take to buy Maplight Therapeutics stock right now:

  1. Figure out where to buy Maplight Therapeutics stock
  2. Create your brokerage account
  3. Fund your brokerage account
  4. Analyze Maplight Therapeutics stock
  5. Place your MPLT trade
  6. Get key alerts regarding your MPLT investment

If you require a brokerage account, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep track of your investment in Maplight Therapeutics, create a watchlist on WallStreetZen today.

NASDAQ: MPLT
$27.96+0.21 (+0.76%)
Updated Jun 15, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: MPLT
$27.96+0.21 (+0.76%)
Updated Jun 15, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Maplight Therapeutics share?

As of Jun 15, 2026, it costs $27.96 to buy one share of Maplight Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.358 shares of MPLT.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Maplight Therapeutics stock?

According to 6 Wall Street analysts who monitor Maplight Therapeutics, their consensus recommendation is to buy Maplight Therapeutics stock.

What is the best way to buy Maplight Therapeutics stock?

One way to place an order for Maplight Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.